Apatinib - Apatinib mesylate | YN968D1 | Rivoceranib mesylate
(Synonyms:N-[4-(1-氰基环戊基)苯基]-2-[(4-吡啶甲基)氨基]-3-吡啶甲酰胺甲磺酸盐;甲磺酸阿帕替尼)
目录号 : KA1155
CAS No. : 1218779-75-9
纯度 : 98%
Potent and selective inhibitor of VEGFR2 tyrosine kinase (IC50 value of 1 nM). Apatinib could also potently suppress the activities of RET, c-KIT and c-Src with IC50 values of 0.13, 0.429 and 0.53 μM, respectively. In vivo, apatinib alone and in combination with chemotherapeutic agents effectively inhibited the growth of several established human tumor xenograft models with little toxicity.
Other Forms of Rapamycin:
KKL Med 的所有产品和服务仅用于科学研究,不能被用于人体,兽医,我们也不向个人提供产品和服务。
KKL 顾客使用本产品发表的 0 篇科研文献
暂无科研文献
| 分子式 |
C25H27N5O4S
|
| 分子量 |
493.58
|
| CAS号 |
1218779-75-9
|
| 中文名称 |
N-[4-(1-氰基环戊基)苯基]-2-[(4-吡啶甲基)氨基]-3-吡啶甲酰胺甲磺酸盐
|
| 储存方式 |
| Powder |
-20°C |
3 years |
| |
4°C |
2 years |
| In solvent |
-80°C |
6 months |
| |
-20°C |
1 month |
|